SUBSCRIBE
SUBSCRIBE

Phase 2

Drug Development
How A Potential Drug And A Possible M&A Could Drive Exelixis Even Higher
August 28, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Seattle’s Omeros Fires Back But Still Won’t Answer Basic Questions About Key Drug
August 24, 2017
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Drug Development
Biogen Gained $1 Billion Overnight After Becoming Goldman Sachs’ Favorite Biotech
August 17, 2017
 · 
3 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Galapagos’ Phase II Results With GLPG1690 are ‘Extremely Exciting’
August 10, 2017
 · 
2 min read
Drug Development
Zynerba’s Failed Cannabidiol Gel Trial Has Upside for Rival GW Pharma
August 8, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Esperion Stock Gains On Strong Phase II Data
August 8, 2017
 · 
2 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
Drug Development
Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug
August 7, 2017
 · 
2 min read
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Drug Development
MyoKardia Shares Surge on Positive Phase II Results for Heart Muscle Disease
August 7, 2017
 · 
3 min read
Drug Development
Roche’s Tecentriq Hits Trouble with NICE in Bladder Cancer
August 3, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Geron Under Pressure as Clinical Trial Changes Causes Delays
August 1, 2017
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
 · 
3 min read
Press Releases
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
May 6, 2026
 · 
2 min read
Press Releases
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
May 6, 2026
 · 
14 min read
Press Releases
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients
May 6, 2026
 · 
5 min read
Press Releases
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results
May 6, 2026
 · 
15 min read
Press Releases
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
May 6, 2026
 · 
10 min read
Press Releases
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
May 6, 2026
 · 
6 min read
Press Releases
Nocion Therapeutics Announces Full Enrollment in Phase 2b ASPIRE Study of Taplucainium for Chronic Cough
May 5, 2026
 · 
3 min read
Press Releases
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
May 5, 2026
 · 
8 min read
Press Releases
Neuraly, Inc. Supports Phase 2 Investigator-Initiated Trial of Pegsebrenatide (NLY01) for Progressive Multiple Sclerosis
May 5, 2026
 · 
3 min read
Press Releases
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026
 · 
19 min read
Press Releases
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
May 5, 2026
 · 
17 min read
Press Releases
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026
 · 
8 min read
Press Releases
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.
May 5, 2026
 · 
6 min read
Press Releases
Altesa BioSciences Enrolls First Patient in Phase 2b CARDINAL Clinical Trial Evaluating Vapendavir as Transformational Treatment for Patients with COPD Impacted by Rhinovirus, the Leading Cause of Exacerbations
May 5, 2026
 · 
4 min read
Press Releases
Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)
May 5, 2026
 · 
11 min read
Press Releases
Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
May 5, 2026
 · 
9 min read
Press Releases
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026
 · 
14 min read
Press Releases
Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
May 5, 2026
 · 
8 min read
Press Releases
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
May 4, 2026
 · 
4 min read
Load More